San Diego-centered Viking Therapeutics marked by itself as a significant competitor from the weight loss drug market place in February right after revealing promising details from the mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection and in March